Axios Alerts: FDA approves Pfizer boosters for high-risk individuals, people 65 and up

Alerts   Axios    FDA approves Pfizer boosters for high-risk individuals, people 65 and up Driving the news: The approval comes days after an advisory panel recommended boosters for the two groups but overwhelmingly voted against the third shots for younger Americans.   Download the Axios App Follow Axios on Social Media Contact Axios, 3100 Clarendon B‌lvd, Suite 1300, Arlington VA 22201   You received this email because you signed up for news alerts from Axios. Change your preferences or unsubscribe here.